Home LiteratureArticle Details
PMID: 8133903 Published · ppublish English Journal Article

Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat.

Naunyn-Schmiedeberg's archives of pharmacology ·Vol. 348 ·No. 6 ·1993-12-00 ·Pages 608-17

Michel AD, Humphrey PP

Abstract

Radioligand binding studies have been performed to study the distribution of the binding sites for the P2x purinoceptor selective agonist radioligand, [3H]alpha,beta-methylene ATP ([3H]alpha beta-meATP), in membranes prepared from various peripheral organs and several brain regions of the rat. In agreement with previous studies in the rat vas deferens, [3H]alpha beta-meATP labelled two populations of sites. One site exhibited high affinity for the ligand (Kd = 0.7 nM; Bmax = 1012 fmol.mg-1 protein) while the other site exhibited lower affinity (Kd = 70.8 nM) and higher capacity (Bmax) = 7470 fmol.mg-1 protein). In competition studies, using a low concentration of radioligand (1 nM), the high affinity alpha beta-meATP binding sites in vas deferens membranes could be preferentially labelled (84-91%). Under these conditions, the P2x purinoceptor agonists, alpha beta-meATP and beta, gamma-methylene ATP, had the highest affinity with pIC50 values of 8.3 and 7.3 respectively. The P2y purinoceptor agonist, 2-methyl-thio-ATP (2-me-S-ATP), had lower affinity (pIC50 = 6.7), while uridine triphosphate, adenosine diphosphate and adenosine, agonists at the P2u, P2t and P1 purinoceptors, respectively, possessed low affinity (pIC50 values < 5.6). In addition, the P2 purinoceptor antagonists, cibacron blue and suramin, inhibited binding over the same concentration range at which they behave as functional antagonists at the P2x purinoceptor. High and low affinity binding sites for [3H]alpha beta-meATP were also identified in a range of other peripheral tissues (spleen, heart and liver) and in several brain regions (striatum, cerebral cortex, hippocampus). In the spleen, heart, cerebral cortex and liver the Kd values at both the high affinity binding sites (Kd = 1-1.2 nM) and the low affinity binding sites (Kd = 98-158 nM) were similar to the respective Kd values at the high and low affinity binding sites in the vas deferens. In competition studies performed using a low concentration of radioligand (1 nM) these sites exhibited a similar pharmacological profile to that seen in the vas deferens. Detailed analysis of competition curves to several of the ATP analogues in each of the tissues revealed that the binding profile of the radioligand was complex since several compounds, and in particular ATP and 2-me-S-ATP, identified a lower proportion of sites with high affinity than did alpha beta-meATP.(ABSTRACT TRUNCATED AT 400 WORDS)

MeSH Terms
Adenosine Triphosphate/analogs & derivatives,metabolism Animals Binding, Competitive/drug effects In Vitro Techniques Male Metals/pharmacology Muscle, Smooth/drug effects,metabolism Purinergic P2 Receptor Antagonists Radioligand Assay Rats Rats, Sprague-Dawley Receptors, Purinergic P2/drug effects,metabolism Temperature Vas Deferens/drug effects,metabolism
Chemicals
Metals Purinergic P2 Receptor Antagonists Receptors, Purinergic P2 Adenosine Triphosphate alpha,beta-methyleneadenosine 5'-triphosphate
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Michel A D
Glaxo Institute of Applied Pharmacology, Department of Pharmacology, University of Cambridge, UK.
Humphrey P P
References (25)
25 references, click to expand
  1. Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides.
    Trends Pharmacol Sci. 1989 Sep;10(9):365-9 PMID: 2690427
  2. Biochemical properties of a P2Y-purinergic receptor.
    Ann N Y Acad Sci. 1990;603:256-66 PMID: 2291525
  3. Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.
    Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):556-60 PMID: 3437923
  4. High- and low-affinity binding sites for [3H]-alpha, beta-methylene ATP in rat urinary bladder membranes.
    Br J Pharmacol. 1990 Oct;101(2):291-6 PMID: 2257437
  5. Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor.
    J Biol Chem. 1989 Apr 15;264(11):6202-6 PMID: 2495280
  6. Signal transduction by P2-purinergic receptors for extracellular ATP.
    Am J Respir Cell Mol Biol. 1991 Apr;4(4):295-300 PMID: 1707633
  7. A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle.
    Nature. 1987 Jul 16-22;328(6127):275-8 PMID: 2439921
  8. Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.
    Br J Pharmacol. 1990 Mar;99(3):617-21 PMID: 2331585
  9. Kinetics and mechanism of L-[3H]nicotine binding to putative high affinity receptor sites in rat brain.
    Mol Pharmacol. 1987 Apr;31(4):392-400 PMID: 3574288
  10. Excitatory effects of adenosine 5'-triphosphate on rat locus coeruleus neurones.
    Eur J Pharmacol. 1992 Mar 17;213(1):71-7 PMID: 1499658
  11. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
    Biochem Pharmacol. 1973 Dec 1;22(23):3099-108 PMID: 4202581
  12. Extracellular ATP: effects, sources and fate.
    Biochem J. 1986 Jan 15;233(2):309-19 PMID: 3006665
  13. The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency.
    Eur J Pharmacol. 1987 Sep 2;141(1):123-30 PMID: 2822441
  14. The paradox of nicotinic acetylcholine receptor upregulation by nicotine.
    Trends Pharmacol Sci. 1990 Jun;11(6):216-9 PMID: 2200178
  15. Solubilization and molecular size determination of the P2x purinoceptor from rat vas deferens.
    J Biol Chem. 1992 Sep 5;267(25):17581-7 PMID: 1387637
  16. The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder.
    Eur J Pharmacol. 1982 Dec 24;86(2):291-4 PMID: 6297936
  17. Ligand: a versatile computerized approach for characterization of ligand-binding systems.
    Anal Biochem. 1980 Sep 1;107(1):220-39 PMID: 6254391
  18. Pharmacology and electrophysiology of ATP-activated ion channels.
    Trends Pharmacol Sci. 1992 Mar;13(3):87-90 PMID: 1374198
  19. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.
    Br J Pharmacol. 1988 Feb;93(2):243-5 PMID: 3359103
  20. Further subclassification of ATP receptors based on agonist studies.
    Trends Pharmacol Sci. 1991 Apr;12(4):137-41 PMID: 2063479
  21. Is there a basis for distinguishing two types of P2-purinoceptor?
    Gen Pharmacol. 1985;16(5):433-40 PMID: 2996968
  22. P1- and P2-purinoceptor subtypes--an update.
    Arch Int Pharmacodyn Ther. 1990 Jan-Feb;303:30-50 PMID: 2196860
  23. The effect of reactive blue, an antagonist of ATP, on the isolated urinary bladders of guinea-pig and rat.
    J Pharm Pharmacol. 1981 Apr;33(4):248-50 PMID: 6115912
  24. ATP receptor-mediated synaptic currents in the central nervous system.
    Nature. 1992 Sep 10;359(6391):144-7 PMID: 1381811
  25. Overview. Purinergic mechanisms.
    Ann N Y Acad Sci. 1990;603:1-17; discussion 18 PMID: 1981306
Article Info
Journal
Naunyn-Schmiedeberg's archives of pharmacology
Abbr.
Naunyn Schmiedebergs Arch Pharmacol
ISSN
0028-1298
Published
1993-12-00
Pages
608-17
Language
English
Region
Germany
NLM ID
0326264
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com